Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector
Gespeichert in:
| Veröffentlicht in: | Molecular therapy 2001-10, Vol.4 (4), p.282-283 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 283 |
|---|---|
| container_issue | 4 |
| container_start_page | 282 |
| container_title | Molecular therapy |
| container_volume | 4 |
| creator | Podsakoff, Greg M. |
| description | |
| doi_str_mv | 10.1006/mthe.2001.0470 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1793349275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525001601904708</els_id><sourcerecordid>4075542261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2790-aadf8da52f30a51aa627f673df8fc67a1124e63cebd7b6b941331253519a929e3</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhq0K1C965QiWOO_ijyTecFuWbltpVRCivVoTZ6J1SeLFdrbqT-u_q6OsygFxmpH1vO945iXkPWdzzljxuYtbnAvG-Jxlih2RU56LfMaYyN689rw4IWchPKSO52VxTE7GKhZCnZLnDfbR7q2Hlt6jic4HutztvAOzpcmbrlrbW0OrIdI1tC39Cub3F3oL0bo-aW76EG0cIgbqGnqN0MYt_YnGdZXtoY_02-2SLuu9Dc4_0ZXrOhsjYkL2Fh9HDdC19SEeBiXLH95FZ1xLG-fpXcAJ-uef78jbBtqAF4d6Tu7Wl79W17PN96ub1XIzM0KVbAZQN4sactFIBjkHKIRqCiXTa2MKBZyLDAtpsKpVVVRlxqXkIpc5L6EUJcpz8mnyTUf5M2CI-sENPu0eNFellFkpVJ6o-UQZ70Lw2Oidtx34J82ZHpPSY1J6TEqPSSXBh4PtUHVY_8UP0STg4wT0EAePr0AXRxMhR4vFRGBaP53T62As9gZr69OJdO3s_6a_ALdMrn0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793349275</pqid></control><display><type>article</type><title>Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Podsakoff, Greg M.</creator><creatorcontrib>Podsakoff, Greg M.</creatorcontrib><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1006/mthe.2001.0470</identifier><identifier>PMID: 11592827</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acquired Immunodeficiency Syndrome - genetics ; Acquired Immunodeficiency Syndrome - therapy ; Advisory Committees ; Anti-HIV Agents - adverse effects ; Anti-HIV Agents - therapeutic use ; Clinical Trials as Topic - methods ; Clinical Trials as Topic - standards ; Consent ; DNA, Recombinant - adverse effects ; DNA, Recombinant - therapeutic use ; Gene therapy ; Genetic Therapy - methods ; Genetic Therapy - standards ; Genetic Vectors - genetics ; HIV ; Human immunodeficiency virus ; Humans ; Infections ; Lentivirus - genetics ; Lymphocytes ; National Institutes of Health (U.S.) ; Patient safety ; United States ; Vectors (Biology)</subject><ispartof>Molecular therapy, 2001-10, Vol.4 (4), p.282-283</ispartof><rights>2001 American Society for Gene Therapy</rights><rights>Copyright Nature Publishing Group Oct 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2790-aadf8da52f30a51aa627f673df8fc67a1124e63cebd7b6b941331253519a929e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1793349275?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11592827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Podsakoff, Greg M.</creatorcontrib><title>Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><subject>Acquired Immunodeficiency Syndrome - genetics</subject><subject>Acquired Immunodeficiency Syndrome - therapy</subject><subject>Advisory Committees</subject><subject>Anti-HIV Agents - adverse effects</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Clinical Trials as Topic - methods</subject><subject>Clinical Trials as Topic - standards</subject><subject>Consent</subject><subject>DNA, Recombinant - adverse effects</subject><subject>DNA, Recombinant - therapeutic use</subject><subject>Gene therapy</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Therapy - standards</subject><subject>Genetic Vectors - genetics</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Lentivirus - genetics</subject><subject>Lymphocytes</subject><subject>National Institutes of Health (U.S.)</subject><subject>Patient safety</subject><subject>United States</subject><subject>Vectors (Biology)</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU1v1DAQhq0K1C965QiWOO_ijyTecFuWbltpVRCivVoTZ6J1SeLFdrbqT-u_q6OsygFxmpH1vO945iXkPWdzzljxuYtbnAvG-Jxlih2RU56LfMaYyN689rw4IWchPKSO52VxTE7GKhZCnZLnDfbR7q2Hlt6jic4HutztvAOzpcmbrlrbW0OrIdI1tC39Cub3F3oL0bo-aW76EG0cIgbqGnqN0MYt_YnGdZXtoY_02-2SLuu9Dc4_0ZXrOhsjYkL2Fh9HDdC19SEeBiXLH95FZ1xLG-fpXcAJ-uef78jbBtqAF4d6Tu7Wl79W17PN96ub1XIzM0KVbAZQN4sactFIBjkHKIRqCiXTa2MKBZyLDAtpsKpVVVRlxqXkIpc5L6EUJcpz8mnyTUf5M2CI-sENPu0eNFellFkpVJ6o-UQZ70Lw2Oidtx34J82ZHpPSY1J6TEqPSSXBh4PtUHVY_8UP0STg4wT0EAePr0AXRxMhR4vFRGBaP53T62As9gZr69OJdO3s_6a_ALdMrn0</recordid><startdate>200110</startdate><enddate>200110</enddate><creator>Podsakoff, Greg M.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200110</creationdate><title>Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector</title><author>Podsakoff, Greg M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2790-aadf8da52f30a51aa627f673df8fc67a1124e63cebd7b6b941331253519a929e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acquired Immunodeficiency Syndrome - genetics</topic><topic>Acquired Immunodeficiency Syndrome - therapy</topic><topic>Advisory Committees</topic><topic>Anti-HIV Agents - adverse effects</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Clinical Trials as Topic - methods</topic><topic>Clinical Trials as Topic - standards</topic><topic>Consent</topic><topic>DNA, Recombinant - adverse effects</topic><topic>DNA, Recombinant - therapeutic use</topic><topic>Gene therapy</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Therapy - standards</topic><topic>Genetic Vectors - genetics</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Lentivirus - genetics</topic><topic>Lymphocytes</topic><topic>National Institutes of Health (U.S.)</topic><topic>Patient safety</topic><topic>United States</topic><topic>Vectors (Biology)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Podsakoff, Greg M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Podsakoff, Greg M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2001-10</date><risdate>2001</risdate><volume>4</volume><issue>4</issue><spage>282</spage><epage>283</epage><pages>282-283</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11592827</pmid><doi>10.1006/mthe.2001.0470</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1525-0016 |
| ispartof | Molecular therapy, 2001-10, Vol.4 (4), p.282-283 |
| issn | 1525-0016 1525-0024 |
| language | eng |
| recordid | cdi_proquest_journals_1793349275 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection |
| subjects | Acquired Immunodeficiency Syndrome - genetics Acquired Immunodeficiency Syndrome - therapy Advisory Committees Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Clinical Trials as Topic - methods Clinical Trials as Topic - standards Consent DNA, Recombinant - adverse effects DNA, Recombinant - therapeutic use Gene therapy Genetic Therapy - methods Genetic Therapy - standards Genetic Vectors - genetics HIV Human immunodeficiency virus Humans Infections Lentivirus - genetics Lymphocytes National Institutes of Health (U.S.) Patient safety United States Vectors (Biology) |
| title | Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A28%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lentiviral%20Vectors%20Approach%20the%20Clinic%20but%20Fall%20Back:%20National%20Institutes%20of%20Health%20Recombinant%20DNA%20Advisory%20Committee%20Review%20of%20a%20First%20Clinical%20Protocol%20for%20Use%20of%20a%20Lentiviral%20Vector&rft.jtitle=Molecular%20therapy&rft.au=Podsakoff,%20Greg%20M.&rft.date=2001-10&rft.volume=4&rft.issue=4&rft.spage=282&rft.epage=283&rft.pages=282-283&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1006/mthe.2001.0470&rft_dat=%3Cproquest_cross%3E4075542261%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1793349275&rft_id=info:pmid/11592827&rft_els_id=S1525001601904708&rfr_iscdi=true |